QTRX - Quanterix Corporation
NEXT EARNINGS:
Mar 2, 2026
(in 5 days)
EPS Est: $-0.27
|
Rev Est: $38.0M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$8.00
DETAILS
HIGH:
$8.00
LOW:
$8.00
MEDIAN:
$8.00
CONSENSUS:
$8.00
UPSIDE:
40.35%
Market Cap:
266.25M
Volume:
731,941
Avg Volume:
682,215
52 Week Range:
4.05-8.77
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
1.07
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
471
IPO Date:
2017-12-07
EPS (TTM):
-1.00
P/E Ratio:
-10.58
Revenue (TTM):
135.44M
Total Assets:
406.53M
Total Debt:
37.37M
Cash & Equiv:
56.71M
Rev Growth (5Y):
19.0%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-14.4%
Debt/Equity:
0.11
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-10 | $-0.36 | $-0.23 | -56.5% | $40.1M | $38.0M | +5.8% |
| 2025-08-07 | $-0.47 | $-0.41 | -14.6% | $24.5M | $38.5M | -36.5% |
| 2025-05-12 | $-0.53 | $-0.69 | +23.2% | $30.3M | $28.3M | +7.1% |
| 2025-03-17 | $-0.30 | $-0.27 | -11.1% | $34.1M | $34.9M | -2.4% |
| 2024-12-23 | $-0.22 | $-0.24 | +8.3% | $35.4M | $34.2M | +3.4% |
| 2024-08-08 | $-0.25 | $-0.27 | +7.4% | $34.1M | $33.7M | +1.3% |
| 2024-05-07 | $-0.26 | $-0.31 | +16.1% | $31.8M | $31.6M | +0.5% |
| 2024-02-29 | $-0.33 | $-0.32 | -3.1% | $31.2M | $29.8M | +4.5% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 135.44M | 121.14M | 105.52M | 110.56M | 86.38M | 56.73M | 37.63M | 22.87M | 17.59M | 12.18M |
| Net Income | (38.53M) | (28.35M) | (99.57M) | (55.55M) | (31.53M) | (40.80M) | (31.05M) | (27.02M) | (23.17M) | (15.94M) |
| EPS | -1.00 | -0.86 | -2.61 | -1.60 | -1.07 | -1.63 | -1.41 | -1.24 | -1.43 | -7.79 |
| Total Assets | 406.53M | 428.57M | 433.58M | 506.51M | 271.05M | 169.95M | 67.63M | 91.78M | 37.12M | 7.35M |
| Total Debt | 37.37M | 41.46M | 44.10M | 21.89M | 30.80M | 7.66M | 7.62M | 9.38M | 10.24M | 9.73M |
| Cash & Equivalents | 56.71M | 174.42M | 338.74M | 396.46M | 181.58M | 109.16M | 45.43M | 79.68M | 29.67M | 2.32M |
| Operating Cash Flow | (35.16M) | (18.90M) | (48.27M) | (47.91M) | (23.36M) | (26.19M) | (28.72M) | (22.11M) | (17.74M) | (12.52M) |
| Free Cash Flow | (38.53M) | (22.69M) | (60.00M) | (61.52M) | (27.30M) | (37.03M) | (30.24M) | (23.24M) | (18.27M) | (13.11M) |
| FCF per Share | -1.00 | -0.60 | -1.62 | -1.71 | -0.92 | -1.48 | -1.37 | -1.07 | -1.13 | -6.41 |
| Book Value | 330.04M | 349.96M | 357.93M | 440.95M | 206.12M | 128.66M | 41.56M | 65.87M | 13.48M | (15.20M) |
| Cash & ST Investments | 289.12M | 321.32M | 338.74M | 396.46M | 181.58M | 109.16M | 45.43M | 79.68M | 29.67M | 2.32M |
| ROC Equity | -0.12 | -0.08 | -0.28 | -0.13 | -0.15 | -0.32 | -0.75 | -0.41 | -1.72 | N/A |